您的位置: 首页 > 农业专利 > 详情页

MG731 Bifidobacterium bifidum MG731 and composition for preventing or treating cancers comprising the same
专利权人:
GENOME AND COMPANY;GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY
发明人:
박한수,박신영,이은주,연제성,전혜희,김원덕,정주연,정아름,허윤경,손진영,김윤연,김상균,이수노,HANSOO PARK,SHINYOUNG PARK,EUN JU LEE,JAE SUNG YEON,HYE HEE JEON,WONDUCK KIM,JOO YEON CHUNG,AREUM JEONG,YOUN KYOUNG HOUH,JINYOUNG SOHN,YUN YEON KIM,SANG GYU
申请号:
KR1020190069415
公开号:
KR1020401170000B1
申请日:
2019.06.12
申请国别(地区):
KR
年份:
2019
代理人:
摘要:
The present invention relates to a novel Bifidobacterium bifidum MG731 strain and a composition for preventing or treating cancer comprising the same. Specifically, the Bifidobacterium bifiderm MG731 strain of the present invention has the effect of inhibiting cancer cell proliferation, reducing cancer cell mobility, suppressing neovascular production, and increasing anti-cancer immune response, while simultaneously reducing cancer or inflammatory disease by reducing the expression of inflammatory factors. It has a prophylactic or therapeutic effect. In addition, the Bifidobacterium bifiderm MG731 strain of the present invention exhibits more excellent anticancer effect when used in combination with a chemical anticancer agent or an immune anticancer agent.본 발명은 신규한 비피도박테리움 비피덤 MG731 (Bifidobacterium bifidum MG731) 균주 및 이를 포함하는 암의 예방 또는 치료용 조성물에 관한 것이다. 구체적으로, 본 발명의 비피도박테리움 비피덤 MG731 균주는 암세포 증식 억제, 암세포 이동성 저하, 신혈관 생성 억제, 항암 면역 반응 증가 효과를 가지면서, 동시에 염증인자의 발현을 감소시킴으로써 암 또는 염증성 질환을 예방 또는 치료하는 효과를 가진다. 또한 본 발명의 비피도박테리움 비피덤 MG731 균주는 화학항암제 또는 면역항암제와 병용되는 경우, 더욱 뛰어난 항암효과를 나타낸다
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充